skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,833  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: subject: General & Internal Medicine remove language: Russian remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
Material Type:
Article 		Add to My Research

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

The Lancet (British edition), 2012-10, Vol.380 (9851), p.1406-1417 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)60734-X ;PMID: 22938757 ;CODEN: LANCAO

Full text available

Citations Cited by
2
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

The Lancet (British edition), 2014-01, Vol.383 (9911), p.31-39 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 4, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)61719-5 ;PMID: 24094768 ;CODEN: LANCAO

Full text available

Citations Cited by
3
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
Material Type:
Article 		Add to My Research

Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial

The Lancet (British edition), 2013-01, Vol.381 (9861), p.125-132 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 12, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61134-9 ;PMID: 23158522 ;CODEN: LANCAO

Full text available

Citations Cited by
4
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9664), p.641-648 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Feb 21-Feb 27, 2009 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)60402-5 ;PMID: 19231632 ;CODEN: LANCAO

Full text available

Citations Cited by
5
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2013-03, Vol.381 (9869), p.817-824 [Peer Reviewed Journal]

Elsevier Ltd ;2014 INIST-CNRS ;Copyright Elsevier Limited Mar 9, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61767-X ;PMID: 23312829 ;CODEN: LANCAO

Full text available

Citations Cited by
6
Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury
Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury
Material Type:
Article 		Add to My Research

Extravascular lung water determined with single transpulmonary thermodilution correlates with the severity of sepsis-induced acute lung injury

Critical care medicine, 2006-06, Vol.34 (6), p.1647 [Peer Reviewed Journal]

ISSN: 0090-3493 ;EISSN: 1530-0293 ;DOI: 10.1097/01.CCM.0000218817.24208.2E ;PMID: 16625129

Digital Resources/Online E-Resources

Citations Cited by
7
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Material Type:
Article 		Add to My Research

Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2014-08, Vol.384 (9941), p.403-413 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Aug 2, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(14)60494-3 ;PMID: 24907225 ;CODEN: LANCAO

Full text available

Citations Cited by
8
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Material Type:
Article 		Add to My Research

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

The Lancet (British edition), 2011, Vol.377 (9767), p.721-731 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 26-Mar 4, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(10)61354-2 ;PMID: 21296403 ;CODEN: LANCAO

Full text available

Citations Cited by
9
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
Material Type:
Article 		Add to My Research

Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study

The Lancet (British edition), 2011-03, Vol.377 (9769), p.914-923 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 12-Mar 18, 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60070-6 ;PMID: 21376385 ;CODEN: LANCAO

Full text available

Citations Cited by
10
Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study
Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study
Material Type:
Article 		Add to My Research

Effect of epidural stimulation of the lumbosacral spinal cord on voluntary movement, standing, and assisted stepping after motor complete paraplegia: a case study

The Lancet (British edition), 2011-06, Vol.377 (9781), p.1938-1947 [Peer Reviewed Journal]

Elsevier Ltd ;2011 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2011 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 4-Jun 10, 2011 ;2011 Elsevier Ltd. All rights reserved. 2011 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)60547-3 ;PMID: 21601270 ;CODEN: LANCAO

Full text available

Citations Cited by
11
Mild post-COVID syndrome in young patients
Mild post-COVID syndrome in young patients
Material Type:
Article 		Add to My Research

Mild post-COVID syndrome in young patients

Terapevtic̆eskii arhiv, 2023-10, Vol.95 (8), p.674-678 [Peer Reviewed Journal]

ISSN: 0040-3660 ;EISSN: 2309-5342 ;DOI: 10.26442/00403660.2023.08.202349 ;PMID: 38158904

Full text available

Citations Cited by
12
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
Material Type:
Article 		Add to My Research

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort

The Lancet (British edition), 2010-01, Vol.375 (9712), p.377-384 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;2015 INIST-CNRS ;Copyright 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jan 30-Feb 5, 2010 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61964-4 ;PMID: 20113825 ;CODEN: LANCAO

Full text available

Citations Cited by
13
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial
Material Type:
Article 		Add to My Research

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial

The Lancet (British edition), 2012-02, Vol.379 (9816), p.633-640 [Peer Reviewed Journal]

Elsevier Ltd ;2012 Elsevier Ltd ;2015 INIST-CNRS ;Copyright © 2012 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 18-Feb 24, 2012 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(11)61847-3 ;PMID: 22257673 ;CODEN: LANCAO

Full text available

Citations Cited by
14
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial
Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial
Material Type:
Article 		Add to My Research

Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial

JAMA : the journal of the American Medical Association, 2010-11, Vol.304 (19), p.2154 [Peer Reviewed Journal]

EISSN: 1538-3598 ;DOI: 10.1001/jama.2010.1672 ;PMID: 21081728

Digital Resources/Online E-Resources

Citations Cited by
15
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial
Material Type:
Article 		Add to My Research

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial

The Lancet (British edition), 2013-03, Vol.381 (9870), p.918-929 [Peer Reviewed Journal]

Elsevier Ltd ;2013 Elsevier Ltd ;2014 INIST-CNRS ;Copyright © 2013 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 16, 2013 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(12)61811-X ;PMID: 23332236 ;CODEN: LANCAO

Full text available

Citations Cited by
16
Clinical importance of evaluation of circulating miRNA expression and epicardial adipose tissue thickness as predictors of cardiovascular pathology in young patients with type 1 diabetes mellitus
Clinical importance of evaluation of circulating miRNA expression and epicardial adipose tissue thickness as predictors of cardiovascular pathology in young patients with type 1 diabetes mellitus
Material Type:
Article 		Add to My Research

Clinical importance of evaluation of circulating miRNA expression and epicardial adipose tissue thickness as predictors of cardiovascular pathology in young patients with type 1 diabetes mellitus

Terapevtic̆eskii arhiv, 2023-11, Vol.95 (10), p.839-844 [Peer Reviewed Journal]

ISSN: 0040-3660 ;EISSN: 2309-5342 ;DOI: 10.26442/00403660.2023.10.202426 ;PMID: 38159015

Full text available

Citations Cited by
17
Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial
Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial
Material Type:
Article 		Add to My Research

Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial

Terapevtic̆eskii arhiv, 2023-11, Vol.95 (10), p.850-858 [Peer Reviewed Journal]

ISSN: 0040-3660 ;EISSN: 2309-5342 ;DOI: 10.26442/00403660.2023.10.202464 ;PMID: 38159017

Full text available

Citations Cited by
18
Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy
Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy
Material Type:
Article 		Add to My Research

Diastolic dysfunction of ventricles in patients with calcium pyrophosphate crystal deposition disease while receiving anti-inflammatory therapy

Terapevtic̆eskii arhiv, 2023-07, Vol.95 (5), p.386-391 [Peer Reviewed Journal]

ISSN: 0040-3660 ;EISSN: 2309-5342 ;DOI: 10.26442/00403660.2023.05.202202 ;PMID: 38158992

Full text available

Citations Cited by
19
Comorbid status of patients with hypertension
Comorbid status of patients with hypertension
Material Type:
Article 		Add to My Research

Comorbid status of patients with hypertension

Terapevtic̆eskii arhiv, 2023-02, Vol.95 (1), p.11-16 [Peer Reviewed Journal]

ISSN: 0040-3660 ;EISSN: 2309-5342 ;DOI: 10.26442/00403660.2023.01.202039 ;PMID: 37167110

Full text available

Citations Cited by
20
Clinical case of mucormycosis in patient COVID-19. Case report
Clinical case of mucormycosis in patient COVID-19. Case report
Material Type:
Article 		Add to My Research

Clinical case of mucormycosis in patient COVID-19. Case report

Terapevtic̆eskii arhiv, 2022-12, Vol.94 (11), p.1320-1325 [Peer Reviewed Journal]

ISSN: 0040-3660 ;EISSN: 2309-5342 ;DOI: 10.26442/00403660.2022.11.201942 ;PMID: 37167172

Full text available

Citations Cited by

Results 1 - 20 of 2,833  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 1981  (316)
  2. 1981 To 1990  (817)
  3. 1991 To 2000  (363)
  4. 2001 To 2011  (707)
  5. After 2011  (631)
  6. More options open sub menu

Language 

  1. English  (390)
  2. Serbian  (9)
  3. Japanese  (4)
  4. Ukrainian  (2)
  5. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait